NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/25/2024
Back to search
Official data from USPTO
AMERICA'S #1 OPHTHALMIC PHARMACY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
AMERICA'S #1 OPHTHALMIC PHARMACY
ST13
US500000097525916Class
44
Filing
97525916
Registration
7430568
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
01/02/2026
Classification
Registered
Trademark type
Word
Nice classes
44
Filing date
07/29/2022
Registration date
06/25/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/25/2024
Last transaction
01/02/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
02/08/2023
First use in commerce
02/08/2023
Drawing code
4
Owner type
16
Owner location
Nashville, TN
Examiner
SANGID,HANA RONNY
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Harrow IP, LLC
Representatives
Laila S. Wolfgram POLSINELLI PC
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Internet-based health care information services; telemedicine services; providing health care information by telephone and the internet; web-based health assessment services, namely, a series of health-related questions for response from the user that result in a report that provides health-related information in the form of recommended educational resources and treatment information; health care services, namely, providing a database in the field of eye health care information that features data and information all for treatment and diagnostic purposes; health screening in the field of ophthalmic services
Publications
History of USPTO decisions and trademark events.
31 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
06/25/2024
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
05/23/2024
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
05/22/2024
IUAA
USE AMENDMENT ACCEPTED
05/22/2024
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
05/20/2024
ALIE
ASSIGNED TO LIE
05/20/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
02/28/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/28/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
02/28/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/28/2024
IUAF
USE AMENDMENT FILED
01/31/2024
EAAU
TEAS AMENDMENT OF USE RECEIVED
01/31/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/31/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/31/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/31/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
10/31/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
10/31/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/31/2023
GNFR
FINAL REFUSAL E-MAILED
07/31/2023
CNFR
FINAL REFUSAL WRITTEN
07/31/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/12/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/12/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/12/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
04/12/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/10/2023
GNRT
NON-FINAL ACTION E-MAILED
03/10/2023
CNRT
NON-FINAL ACTION WRITTEN
03/10/2023
DOCK
ASSIGNED TO EXAMINER
02/24/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/02/2022
NWAP
NEW APPLICATION ENTERED
08/02/2022
Continuous trademark protection
Get notified about every new filing that threatens AMERICA'S #1 OPHTHALMIC PHARMACY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.